Dopamine D1-like receptors play only a minor role in the increase of striatal dopamine induced by striatally applied SKF38393

European Journal of Pharmacology

Volumn 648, Issue 1-3, 2010, Pages 80-86

  Sekino, Reiko ^a   Saigusa, Tadashi ^a   Aono, Yuri ^a   Uchida, Takuya ^a   Takada, Koji ^a   Oi, Yoshiyuki ^a   Koshikawa, Noriaki ^a   Cools, Alexander R ^b  

^a NIHON UNIVERSITY   (Japan)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

(Rat); Ca2+; Dopamine; Microdialysis; SKF38393; Striatum

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BENZAZEPINE DERIVATIVE; FELYPRESSIN; ISOTONIC SOLUTION; OXYMETAZOLINE; RINGER'S SOLUTION; VASOCONSTRICTOR AGENT; VASOPRESSIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOSE RESPONSE; DRUG MECHANISM; GLIA CELL; HISTOLOGY; LOW DRUG DOSE; MALE; NERVE ENDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR UPREGULATION; ANIMAL; ARTERIOLE; CYTOLOGY; DRUG EFFECT; EXTRACELLULAR SPACE; IN VITRO STUDY; INJECTION; METABOLISM; NEOSTRIATUM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION; VASOCONSTRICTION; VENULE;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; ARTERIOLES; BENZAZEPINES; DOPAMINE; EXTRACELLULAR SPACE; FELYPRESSIN; INJECTIONS; ISOTONIC SOLUTIONS; MALE; NEOSTRIATUM; OXYMETAZOLINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, VASOPRESSIN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VENULES;

EID: 77957751664     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.08.031     Document Type: Article

References (39)

1. 2 dopamine receptors in rat striatum under freely moving conditions. Brain Res. 1990, 518:193-198.
2. Alborch E., Salom J.B., Torregrosa G. Calcium channels in cerebral arteries. Pharmacol. Ther. 1995, 68:1-34.
3. Amenta F., Ricci A., Vega J.A. Autoradiographic localization of dopamine receptors in rat cerebral blood vessels. Eur. J. Pharmacol. 1991, 192:123-132.
4. Andersson K.E., Edvinsson L., MacKenzie E.T., Skärby T., Young A.R. Influence of extracellular calcium and calcium antagonists on contractions induced by potassium and prostaglandin F2 alpha in isolated cerebral and mesenteric arteries of the cat. Br. J. Pharmacol. 1983, 79:135-140.
5. Benveniste H., Hüttemeier P.C. Microdialysis-theory and application. Prog. Neurobiol. 1990, 35:195-215.
6. Benveniste H., Hansen A.J., Ottosen N.S. Determination of brain interstitial concentrations by microdialysis. J. Neurochem. 1989, 52:1741-1750.
7. Benwell M.E., Balfour D.J., Lucchi H.M. Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine. Psychopharmacology (Berl.) 1993, 112:467-474.
8. Carboni E., Imperato A., Perezzani L., Di Chiara G. Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 1989, 28:653-661.
9. Chen Z.J., Minneman K.P. Recent progress in alpha1-adrenergic receptor research. Acta Pharmacol. Sin. 2005, 26:1281-1287.
10. Cools A.R., Ellenbroek B., van den Bos R., Gelissen M. Mesolimbic noradrenaline: specificity, stability and dose-dependency of individual-specific responses to mesolimbic injections of alpha-noradrenergic agonists. Behav. Brain Res. 1987, 25:49-61.
11. Edvinsson L., McCulloch J., Sharkey J. Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists. Br. J. Pharmacol. 1985, 85:403-410.
12. 3 receptors in the dorsal striatum, but not in the nucleus accumbens. Eur. J. Pharmacol. 2002, 448:143-150.
13. Fusa K., Takahashi I., Watanabe S., Aono Y., Ikeda H., Saigusa T., Nagase H., Suzuki T., Koshikawa N., Cools A.R. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals. Neuroscience 2005, 130:743-753.
14. Gray A.M., Rawls S.M., Shippenberg T.S., McGinty J.F. The kappa-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum. J. Neurochem. 1999, 73:1066-1074.
15. Habuchi Y., Tanaka H., Nishio M., Yamamoto T., Komori T., Morikawa J., Yoshimura M. Dopamine stimulation of cardiac beta-adrenoceptors: the involvement of sympathetic amine transporters and the effect of SKF38393. Br. J. Pharmacol. 1997, 122:1669-1678.
16. Högestätt E.D., Andersson K.-E. On the postjunctional α-adrenoreceptors in rat cerebral and mesenteric arteries. J. Auton. Pharmacol. 1984, 4:161-173.
17. Imperato A., Di Chiara G. Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites. J. Neurosci. 1984, 4:966-977.
18. Iversen L. Neurotransmitter transporters and their impact on the development of psychopharmacology. Br. J. Pharmacol. 2006, 147(Suppl. 1):S82-S88.
19. 2 antagonists on the transient increase of dopamine release by dopamine agonists by means of brain dialysis. Neurosci. Lett. 1991, 133:77-80.
20. Lindefors N., Amberg G., Ungerstedt U. Intracerebral microdialysis: I. Experimental studies of diffusion kinetics. J. Pharmacol. Methods 1989, 22:141-156.
21. Manning M., Stoev S., Chini B., Durroux T., Mouillac B., Guillon G. Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. Prog. Brain Res. 2008, 170:473-512.
22. Miyazaki I., Asanuma M., Diaz-Corrales F.J., Miyoshi K., Ogawa N. Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia. Brain Res. 2004, 1029:120-123.
23. Nakai K., Itakura T., Naka Y., Nakakita K., Kamei I., Imai H., Yokote H., Komai N. The distribution of adrenergic receptors in cerebral blood vessels: an autoradiographic study. Brain Res. 1986, 381:148-152.
24. Østergaard K., Schou J.P., Zimmer J. Rat ventral mesencephalon grown as organotypic slice cultures and co-cultured with striatum, hippocampus, and cerebellum. Exp. Brain Res. 1990, 82:547-565.
25. Paxinos G., Watson C. The Rat Brain in Sterotaxic Coordinates 1998, Academic Press, New York. 4th edn.
26. Saigusa T., Takada K., Baker S.C., Kumar R., Stephenson J.D. Dopamine efflux in the rat nucleus accumbens evoked by dopamine receptor stimulation in the entorhinal cortex is modulated by oestradiol and progesterone. Synapse 1997, 25:37-43.
27. Saigusa T., Tuinstra T., Koshikawa N., Cools A.R. High and low responders to novelty: effects of a catecholamine synthesis inhibitor on novelty-induced changes in behavior and release of accumbal dopamine. Neuroscience 1999, 88:1153-1163.
28. Saigusa T., Fusa K., Okutsu H., Koshikawa N. Monitoring of extracellular dopamine levels in the dorsal striatum and the nucleus accumbens with 5-minute on-line microdialysis in freely moving rats. J. Oral Sci. 2001, 43:129-134.
29. B receptors in the endomorphin-1-, but not endomorphin-2-, induced dopamine efflux in the nucleus accumbens of freely moving rats. Eur. J. Pharmacol. 2008, 581:276-282.
30. Saigusa T., Aono Y., Sekino R., Uchida T., Takada K., Oi Y., Koshikawa N., Cools A.R. Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of SKF38393. Eur. J. Pharmacol. 2009, 624:10-15.
31. ++. Stroke 1986, 17:95-97.
32. 2-adrenoceptor-mediated contractile responses in isolated rat and cat cerebral and mesenteric arteries. Acta Physiol. Scand. 1985, 123:445-456.
33. Sun M.H., Ishine T., Lee T.J. Dopamine constricts porcine pial veins. Eur. J. Pharmacol. 1997, 334:165-171.
34. Tomiyama K., Noguchi M., Koshikawa N., Kobayashi M. YM-09151-2 but not l-sulpiride induces transient dopamine release in rat striatum via a tetrodotoxin-insensitive mechanism. J. Neurochem. 1993, 60:1690-1695.
35. Tomiyama K., Koshikawa N., Funada K., Oka K., Kobayashi M. In vivo microdialysis evidence for transient dopamine release by benzazepines in rat striatum. J. Neurochem. 1995, 65:2790-2795.
36. Verheij M.M., Cools A.R. Twenty years of dopamine research: individual differences in the response of accumbal dopamine to environmental and pharmacological challenges. Eur. J. Pharmacol. 2008, 585:228-244.
37. Watanabe S., Aono Y., Fusa K., Takada K., Saigusa T., Koshikawa N., Cools A.R. Contribution of vesicular and cytosolic dopamine to the increased striatal dopamine efflux elicited by intrastriatal injection of dexamphetamine. Neuroscience 2005, 136:251-257.
38. Westerink B.H., De Vries J.B. Characterization of in vivo dopamine release as determined by brain microdialysis after acute and subchronic implantations: methodological aspects. J. Neurochem. 1988, 51:683-687.
39. 2-like receptors. J. Neurochem. 2006, 98:481-494.